This mechanism distinguishes it from semaglutide, which primarily targets GLP-1, and tirzepatide, which targets GLP-1 and GIP
Research domains include obesity, metabolic regulation, and combination incretin-based therapies
Common combinations functional medicine providers use include Tesamorelin or CJC-1295 for fat-loss leverage, MOTS-c for mitochondrial support, BPC-157 for recovery between training sessions, and 5-Amino-1MQ for NNMT-driven recomposition
Main Takeaways: Why controlling variables matters for supplement evaluation How diet changes can mask or amplify recovery results The hidden benefit of "messy" real-world experiments A systematic approach to learning from imperfect data Episodes Mentioned: Testosterone, Hormone Therapy, and Peptides for Health and Longevity with Dr
Specifically, BPC-157 has been shown to reduce the levels of Interleukin-1 beta (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-)
blocks ferritin iron release (87% lipid peroxidation)